Literature DB >> 14997002

Vascular endothelial growth factor gene polymorphisms and pre-eclampsia.

Dimitrios Papazoglou1, Georgios Galazios, Michael I Koukourakis, Ioannis Panagopoulos, Emmanuel N Kontomanolis, Konstantinos Papatheodorou, Efstratios Maltezos.   

Abstract

Vascular endothelial growth factor (VEGF) plays a crucial role in physiological vasculogenesis and vascular permeability and has been implicated in the pathogenesis of pre-eclampsia. Our present study was undertaken to identify associations between three functional VEGF gene polymorphisms, linked with altered VEGF gene responsiveness, and pre-eclampsia. The study involved 42 pre-eclamptic and 73 healthy control women who were genotyped for the -2578C/A, -634G/C and 936C/T polymorphisms of the VEGF gene. No significant association between genotypic or allelic frequencies in women with pre-eclampsia relative to controls was found. A statistically significant difference was found for allelic frequencies of the 936C/T polymorphism between women with severe pre-eclampsia and controls (odds ratio: 2.70; 95% confidence interval: 1.09-6.63; P = 0.019). VEGF gene polymorphisms studied are unlikely to be major predisposing factors for pre-eclampsia. The presence of the 936T allele probably has a considerable effect on disease modification.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997002     DOI: 10.1093/molehr/gah048

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  18 in total

1.  No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.

Authors:  Ilke H Onen; Ece Konac; Muzaffer Eroglu; Cagri Guneri; Hasan Biri; Abdullah Ekmekci
Journal:  Mol Biol Rep       Date:  2007-01-11       Impact factor: 2.316

2.  Polymorphisms in the 5'- and 3'-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics.

Authors:  Cristiane Oliveira; Gustavo J Lourenço; Priscilla M R Silva; Cassio Cardoso-Filho; Maira H C Favarelli; Neiva S L Gonçales; Maria S C Gurgel; Carmen S P Lima
Journal:  Tumour Biol       Date:  2010-10-28

3.  Preeclampsia and the Anti-Angiogenic State.

Authors:  Isha Agarwal; S Ananth Karumanchi
Journal:  Pregnancy Hypertens       Date:  2011-01-01       Impact factor: 2.899

4.  Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age.

Authors:  Liora Madar-Shapiro; Ido Karady; Alla Trahtenherts; Argryo Syngelaki; Ranjit Akolekar; Liona Poon; Ruth Cohen; Adi Sharabi-Nov; Berthold Huppertz; Marei Sammar; Kata Juhasz; Nandor Gabor Than; Zoltan Papp; Roberto Romero; Kypros H Nicolaides; Hamutal Meiri
Journal:  Fetal Diagn Ther       Date:  2017-07-21       Impact factor: 2.587

5.  VEGF-A and VEGFR1 SNPs associate with preeclampsia in a Philippine population.

Authors:  Melissa D Amosco; Van Anthony M Villar; Justin Michael A Naniong; Lara Marie G David-Bustamante; Pedro A Jose; Cynthia P Palmes-Saloma
Journal:  Clin Exp Hypertens       Date:  2016-09-26       Impact factor: 1.749

6.  Increase levels of apo-A1 and apo B are associated in knee osteoarthritis: lack of association with VEGF-460 T/C and +405 C/G polymorphisms.

Authors:  Sergio Sánchez-Enríquez; Nora Magdalena Torres-Carrillo; Mónica Vázquez-Del Mercado; Lorenzo Salgado-Goytia; Héctor Rangel-Villalobos; José Francisco Muñoz-Valle
Journal:  Rheumatol Int       Date:  2008-07-03       Impact factor: 2.631

Review 7.  Vascular and cellular calcium in normal and hypertensive pregnancy.

Authors:  Zuzana Adamova; Sifa Ozkan; Raouf A Khalil
Journal:  Curr Clin Pharmacol       Date:  2009-09-01

8.  Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.

Authors:  Moon Ju Jang; Jong Woo Kim; Young Joo Jeon; So Young Chong; Doyeun Oh; Nam Keun Kim
Journal:  Int J Clin Oncol       Date:  2012-11-07       Impact factor: 3.402

9.  Polymorphisms in the hypoxia-inducible factor 1 alpha gene in Mexican patients with preeclampsia: A case-control study.

Authors:  Sonia Nava-Salazar; Elly N Sánchez-Rodríguez; C Adriana Mendoza-Rodríguez; Carlos Moran; Juan F Romero-Arauz; Marco A Cerbón
Journal:  BMC Res Notes       Date:  2011-03-17

10.  The role of genetics in pre-eclampsia and potential pharmacogenomic interventions.

Authors:  Paula Juliet Williams; Linda Morgan
Journal:  Pharmgenomics Pers Med       Date:  2012-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.